{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T17:10:34Z","timestamp":1763226634562},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41429-018-0120-5","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T09:41:13Z","timestamp":1543570873000},"page":"114-117","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fluorescence assay to predict activity of the glycopeptide antibiotics"],"prefix":"10.1038","volume":"72","author":[{"given":"Vladimir","family":"Vimberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"Gazak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Sz\u0171cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniko","family":"Borb\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pal","family":"Herczegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorunn Pauline","family":"Cavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona","family":"Zieglerova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Z\u00e1vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e1clava","family":"Ad\u00e1mkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Balikova Novotna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"120_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10096-010-1142-5","volume":"30","author":"K Krist\u00f3f","year":"2011","unstructured":"Krist\u00f3f K, et al. Significance of methicillin-teicoplanin resistant Staphylococcus haemolyticus in bloodstream infections in patients of the Semmelweis University hospitals in Hungary. Eur J Clin Microbiol Infect Dis. 2011;30:691\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"120_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","volume":"10","author":"CA Arias","year":"2012","unstructured":"Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10:266\u201378.","journal-title":"Nat Rev Microbiol"},{"key":"120_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ja.2014.111","volume":"67","author":"MS Butler","year":"2014","unstructured":"Butler MS, Hansford Ka, Blaskovich MAT, Halai R, Cooper MA. Glycopeptide antibiotics: back to the future. J Antibiot (Tokyo). 2014;67:631\u201344.","journal-title":"J Antibiot (Tokyo)"},{"key":"120_CR4","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1093\/cid\/cir920","volume":"54","author":"GG Zhanel","year":"2012","unstructured":"Zhanel GG, Schweizer F, Karlowsky JA. Oritavancin: mechanism of action . Clin Infect Dis. 2012;54:S214\u20139.","journal-title":"Clin Infect Dis"},{"key":"120_CR5","first-page":"59","volume":"41","author":"TM Blostica","year":"2006","unstructured":"Blostica TM, Klepser ME. Dalbavancin: a novel long-acting lipoglycopeptide antibiotic. Formulary. 2006;41:59\u201373.","journal-title":"Formulary"},{"key":"120_CR6","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G417","author":"L Charneski","year":"2009","unstructured":"Charneski L, Patel PN, Sym D. Telavancin: a novel lipoglycopeptide antibiotic. Ann Pharmacother. 2009. \n                    https:\/\/doi.org\/10.1345\/aph.1G417","journal-title":"Ann Pharmacother"},{"key":"120_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026989","author":"D Zeng","year":"2016","unstructured":"Zeng D, et al. Approved glycopeptide antibacterial drugs: mechanism of action and resistance. Cold Spring Harb Perspect Med. 2016. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a026989","journal-title":"Cold Spring Harb Perspect Med"},{"key":"120_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-010-9628-z","author":"T Jarzembowski","year":"2010","unstructured":"Jarzembowski T, J\u00f3\u017awik A, Wi\u015bniewska K, Witkowski J. Flow cytometry approach study of enterococcus faecalis vancomycin resistance by detection of vancomycin@fl binding to the bacterial cells. Curr Microbiol. 2010. \n                    https:\/\/doi.org\/10.1007\/s00284-010-9628-z","journal-title":"Curr Microbiol"},{"key":"120_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv007","author":"JR Smith","year":"2014","unstructured":"Smith JR, et al. \u03b2-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother. 2014. \n                    https:\/\/doi.org\/10.1093\/jac\/dkv007","journal-title":"J Antimicrob Chemother"},{"key":"120_CR10","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/jm900950d","volume":"52","author":"G Pint\u00e9r","year":"2009","unstructured":"Pint\u00e9r G, et al. Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study. J Med Chem. 2009;52:6053\u201361.","journal-title":"J Med Chem"},{"key":"120_CR11","doi-asserted-by":"crossref","unstructured":"Cs\u00e1v\u00e1s, M et al. Synthesis and antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl- and arylthiosubstituted maleimides. J Antibiot (Tokyo). 2015;68:579\u201385.","DOI":"10.1038\/ja.2015.33"},{"key":"120_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2016.80","author":"Z Szucs","year":"2017","unstructured":"Szucs Z, et al. Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function. J Antibiot (Tokyo). 2017. \n                    https:\/\/doi.org\/10.1038\/ja.2016.80","journal-title":"J Antibiot (Tokyo)"},{"key":"120_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JB.00278-17","volume":"199","author":"JD Chang","year":"2017","unstructured":"Chang JD, Foster EE, Thadani AN, Ramirez AJ, Kim SJ. Crossm inhibition of Staphylococcus aureus cell wall biosynthesis by desleucyl-oritavancin: a quantitative peptidoglycan composition analysis by mass spectrometry. J Bacteriol. 2017;199:1\u201312.","journal-title":"J Bacteriol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0120-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0120-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0120-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:33Z","timestamp":1684618293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-018-0120-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1038\/s41429-018-0120-5","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"25 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}